|
SBIR TOPIC 342 - DIRECT TO PHASE II SBIR CONTRACT - A WEARABLE SYSTEM FOR ASSESSMENT OF FALL RISK ASSOCIATED WITH CANCER TREATMENT; PERIOD OF PERFORMANCE: 09/19/2016 - 09/18/2018.
|
261201600067C
|
$1,457,589
|
$728,795
|
EL-GOHARY, MAHMOUD
|
APDM, INC.
|
|
Control of CMV infection post-HCT using attenuated MVA-based CMV subunit vaccine
|
4R01CA077544-15
|
$539,228
|
$539,228
|
DIAMOND, DON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
CMVPepVax to Protect HCT Recipients from Cytomegalovirus Infection
|
5R01CA181045-03
|
$710,976
|
$710,976
|
DIAMOND, DON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Image-guided irradiation safely intensifies HSCT regimen for refractory leukemia
|
1R01CA195519-01A1
|
$272,213
|
$272,213
|
FORMAN, STEPHEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S1
|
$125,651
|
$12,565
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S2
|
$124,999
|
$12,500
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S3
|
$37,400
|
$3,740
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S4
|
$350,000
|
$35,000
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
4P30CA033572-33
|
$2,520,000
|
$252,000
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Novel AHCT Regimen for Advanced Hodgkin Lymphoma using Y-90 anti-CD25 with BEAM
|
5R21CA185875-02
|
$174,122
|
$174,122
|
SMITH, EILEEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Stem Cell Gene Therapy Following R-EPOCH for Non-Hodgkin Lymphoma in AIDS Patient
|
5U01CA183012-03
|
$106,075
|
$106,075
|
ZAIA, JOHN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Effects of PGE2 on reconstitution of hematopoiesis and immunity after UCBT
|
3R01CA183605-04S1
|
$355,157
|
$355,157
|
BOUSSIOTIS, VASSILIKI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Effects of PGE2 on reconstitution of hematopoiesis and immunity after UCBT
|
4R01CA183605-04
|
$536,875
|
$536,875
|
BOUSSIOTIS, VASSILIKI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Development of Novel Therapeutic Strategies in Human Leukemias
|
5P01CA066996-18
|
$2,249,567
|
$179,965
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Bone Deficits and Excess Adiposity after Pediatric Bone Marrow Transplantation
|
4K07CA166177-04
|
$164,901
|
$164,901
|
MOSTOUFI-MOAB, SOGOL
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Novel Role(s) of Nrf2 in the Growth of Post-Transplantation Cancer
|
1R01CA193675-01A1
|
$411,185
|
$411,185
|
PAL, SOUMITRO
|
CHILDREN'S HOSPITAL CORPORATION
|
|
KIR-FAVORABLE HAPLOIDENTICAL TRANSPLANTATION IN CHILDREN
|
7R01CA181050-03
|
$370,071
|
$370,071
|
PULSIPHER, MICHAEL
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
New Frontiers in Pediatric Stem Cell Transplantation
|
1R13CA206376-01
|
$5,000
|
$5,000
|
JACOBSOHN, DAVID
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Nonadherence: Undermining health outcomes in pediatric HSCT?
|
4R01CA157460-05
|
$407,809
|
$407,809
|
PAI, AHNA
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Targeting Cdc42 for bone marrow transplant therapies
|
5R01CA193350-02
|
$356,850
|
$356,850
|
ZHENG, YI
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Cancer Center Support Grant
|
3P30CA006516-51S1
|
$122,500
|
$3,675
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S2
|
$37,500
|
$1,125
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S3
|
$125,000
|
$3,750
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S4
|
$200,000
|
$6,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S5
|
$60,000
|
$1,800
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S6
|
$199,953
|
$5,999
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S7
|
$500,000
|
$15,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S8
|
$750,000
|
$22,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
4P30CA006516-51
|
$11,151,311
|
$334,539
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease
|
5P01CA142106-12
|
$1,630,446
|
$1,630,446
|
CUTLER, COREY
|
DANA-FARBER CANCER INST
|
|
Reconstitution of Regulatory T Cells After Stem Cell Transplantation
|
5R01CA183560-04
|
$500,000
|
$500,000
|
RITZ, JEROME
|
DANA-FARBER CANCER INST
|
|
Manipulation of Immune Responsiveness after Hematopoietic Cell Transplantation
|
4R01CA183559-04
|
$700,000
|
$700,000
|
SOIFFER, ROBERT
|
DANA-FARBER CANCER INST
|
|
Patient-centered home-based hematopoietic stem cell transplantation
|
1R01CA203950-01
|
$659,848
|
$659,848
|
CHAO, NELSON
|
DUKE UNIVERSITY
|
|
Role of ErbB receptor signaling in regulating normal and leukemic stem cell fate
|
5K08CA184552-03
|
$127,865
|
$38,360
|
DOAN, PHUONG
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-42S1
|
$133,481
|
$5,339
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-42S2
|
$200,000
|
$8,000
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA014236-42
|
$5,679,062
|
$227,162
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Dissecting mechanism(s) by which ionizing radiation promotes clonal expansion of premalignant cells in the thymus
|
1K99CA212198-01
|
$113,130
|
$113,130
|
LEE, CHANG LUNG
|
DUKE UNIVERSITY
|
|
Novel Strategies for Cancer Immunotherapy in Stem Cell Transplant
|
5R01CA136934-08
|
$357,750
|
$357,750
|
YANG, YIPING
|
DUKE UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-08S1
|
$59,999
|
$1,200
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
4P30CA138292-08
|
$2,038,828
|
$40,777
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Using donor pDC to optimize GvHD and GvL in allogeneic stem cell transplantation
|
5R01CA188523-03
|
$323,700
|
$323,700
|
WALLER, EDMUND
|
EMORY UNIVERSITY
|
|
Adult Leukemia Research Center
|
4P01CA018029-41
|
$4,225,448
|
$2,197,233
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Career Development in Pediatric and Medical Oncology
|
2K12CA076930-16A1
|
$531,466
|
$265,733
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Pediatric Oncology Research Training Program
|
4T32CA009351-38
|
$248,472
|
$99,389
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeting Leukemia with Memory CD8+ T cells Transduced to Express High-Affinity W
|
4K08CA169485-04
|
$171,372
|
$171,372
|
CHAPUIS, AUDE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Investigating the role of interleukin-22 in thymus function
|
4R00CA176376-02
|
$248,996
|
$124,498
|
DUDAKOV, JARROD
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-41S1
|
$78,024
|
$7,802
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-41S2
|
$249,999
|
$25,000
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-41S3
|
$125,000
|
$12,500
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Total relevant funding to Organ Transplantation Research for this search: $52,014,489
|